Commit Biologics Holding ApS: Financial statements 2025
CVR: 42604232
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Commit Biologics Holding ApS (CVR 42604232) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -10,093 and a net result of DKK -12,988 compared with DKK -14,948 the year before. Equity in the 2025 report amounted to DKK -18,193.
- Gross Profit
- DKK -10,093
- Profit/Loss
- DKK -12,988
- Equity
- DKK -18,193
- Total Assets
- DKK 49,806
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -10 t. | -13 t. | -18 t. | 0 |
| 2024 | - | -12 t. | -15 t. | -5 t. | 0 |
| 2023 | - | -12 t. | -13 t. | 10 t. | 0 |
How creditworthy is Commit Biologics Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Commit Biologics Holding ApS has published its annual report for 2024. Gross profit came to DKK -11,750, and the net result was DKK -14,948.
About Commit Biologics Holding ApS
Commit Biologics Holding ApS is a Danish company of the type Anpartsselskab based in Auning, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. The company's owners include Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. In 2025, the company reported a gross profit of DKK -10,093 and a net result of DKK -12,988 compared with DKK -14,948 the year before. Equity in the 2025 report amounted to DKK -18,193.